1. Signaling Pathways
  2. Others
  3. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (2203):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-I0510
    Carfilzomib intermediate-1
    Carfilzomib intermediate-1 (Intermediate IV) is a key intermediate for Carfilzomib (HY-10455) synthesis.
    Carfilzomib intermediate-1
  • HY-Z0422
    3,5-Dimethylbenzonitrile
    99.55%
    3,5-Dimethylbenzonitrile is a drug impurity.
    3,5-Dimethylbenzonitrile
  • HY-W076424
    Remimazolam impurity 4
    Remimazolam impurity 4 is an impurity of Remimazolam.
    Remimazolam impurity 4
  • HY-I0496
    Linagliptin impurity 34
    99.81%
    Linagliptin impurity 34 is an impurity of Linagliptin (HY-10284).
    Linagliptin impurity 34
  • HY-I0278
    Tofacitinib impurity 32
    99.53%
    Tofacitinib impurity 32 is an impurity of Tofacitinib (HY-40354).
    Tofacitinib impurity 32
  • HY-23326
    (2S,5S)-Methyl 5-phenylpyrrolidine-2-carboxylate hydrochloride
    98.50%
    (2S,5S)-Methyl 5-phenylpyrrolidine-2-carboxylate hydrochloride is a drug intermediate for synthesis of various active compounds.
    (2S,5S)-Methyl 5-phenylpyrrolidine-2-carboxylate hydrochloride
  • HY-75882
    Ethyl 4-(2-chloropyridin-3-ylamino)piperidine-1-carboxylate
    Ethyl 4-(2-chloropyridin-3-ylamino)piperidine-1-carboxylate (1-Piperidinecarboxylic acid, 4-[(2-chloro-3-pyridinyl)amino]-, ethyl ester) is a drug intermediate for synthesis of various active compounds.
    Ethyl 4-(2-chloropyridin-3-ylamino)piperidine-1-carboxylate
  • HY-Z8691
    Timolol impurity 1
    98.75%
    Timolol impurity 1 is an impurity of Timolol (HY-17494).
    Timolol impurity 1
  • HY-20195A
    3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
    3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile is a drug intermediate for synthesis of various active compounds.
    3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
  • HY-N8651
    2'-Hydroxy-3,4-dimethoxydihydrochalcone
    2'-Hydroxy-3,4-dimethoxydihydrochalcone is a drug intermediate for synthesis of various active compounds.
    2'-Hydroxy-3,4-dimethoxydihydrochalcone
  • HY-W000618
    3-Chloro-2-isobutoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
    3-Chloro-2-isobutoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is a drug intermediate for synthesis of various active compounds.
    3-Chloro-2-isobutoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
  • HY-W206016
    3-Aminosalicylic acid
    99.06%
    3-Aminosalicylic acid is the impurity found during the 5-Aminosalicylic acid (HY-15027) production. 5-Aminosalicylic acid is the agonist for PPARγ and the inhibitor for p21-activated kinase 1 (PAK1) and NF-κB. Crohn's disease, ulcerative proctitis
    3-Aminosalicylic acid
  • HY-43552
    2-Amino-6-fluoro-4-(2-methoxyethoxy)benzonitrile
    98.75%
    2-Amino-6-fluoro-4-(2-methoxyethoxy)benzonitrile is a drug intermediate for synthesis of various active compounds.
    2-Amino-6-fluoro-4-(2-methoxyethoxy)benzonitrile
  • HY-Z2264
    Afatinib impurity 36
    Afatinib impurity 36 is an impurity of Afatinib (HY-10261).
    Afatinib impurity 36
  • HY-50806
    (1R,2R)-2-(4-Bromobenzoyl)cyclopentane-1-carboxylic acid
    99.25%
    (1R,2R)-2-(4-Bromobenzoyl)cyclopentane-1-carboxylic acid is a drug intermediate for synthesis of various active compounds.
    (1R,2R)-2-(4-Bromobenzoyl)cyclopentane-1-carboxylic acid
  • HY-Z0480
    Cannabidiol impurity 1
    Cannabidiol impurity 1 is an impurity of Cannabidiol.
    Cannabidiol impurity 1
  • HY-76089
    tert-Butyl 3-(1-amino-2-methylpropan-2-yl)-1H-indole-1-carboxylate
    tert-Butyl 3-(1-amino-2-methylpropan-2-yl)-1H-indole-1-carboxylate (3-(2-Amino-1,1-dimethylethyl)-indole-1-carboxylic acid tert-butyl ester) is a drug intermediate for synthesis of various active compounds.
    tert-Butyl 3-(1-amino-2-methylpropan-2-yl)-1H-indole-1-carboxylate
  • HY-Z4491
    6,7-Dihydropyrazino[2,3-d]pyridazine-5,8-dione
    6,7-Dihydropyrazino[2,3-d]pyridazine-5,8-dione impurity is a drug impurity.
    6,7-Dihydropyrazino[2,3-d]pyridazine-5,8-dione
  • HY-23565
    (R)-1,4-Dibenzyl-2-(chloromethyl)piperazine
    99.10%
    (R)-1,4-Dibenzyl-2-(chloromethyl)piperazine is a drug intermediate for synthesis of various active compounds.
    (R)-1,4-Dibenzyl-2-(chloromethyl)piperazine
  • HY-W008727
    Amodiaquine impurity 1
    98.70%
    Amodiaquine impurity 1 is an impurity of Amodiaquine (HY-B1322A).
    Amodiaquine impurity 1